Physician profile
Patrick Donovan
NPI 1679579619
$3,047.29
in general payments reported to CMS, 2019-2025
39 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,033 · 2020: $14.44.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tesaro, INC. | $459.77 | 2019 | |
| Novartis Pharmaceuticals Corporation | $322.57 | 2019 | |
| Pfizer INC. | $195.62 | 2019 | |
| Genentech USA, INC. | $179.65 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $142.76 | 2019 | |
| Merck Sharp & Dohme LLC | $139.00 | 2019 | |
| Amgen INC. | $136.17 | 2019 | |
| Puma Biotechnology, INC. | $122.37 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $121.59 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $118.04 | 2019 | |
| Janssen Biotech, INC. | $96.14 | 2019 | |
| Exelixis INC. | $87.87 | 2019 | |
| Astellas Pharma US INC | $77.29 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.32 | 2019 | |
| Genzyme Corporation | $67.21 | 2019 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $60.52 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $55.29 | 2019 | |
| Emd Serono, INC. | $55.13 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.14 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $44.66 | 2019 | |
| Incyte Corporation | $44.61 | 2019 | |
| Rigel Pharmaceuticals, INC. | $42.82 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $37.62 | 2019 | |
| Alexion Pharmaceuticals, INC. | $32.05 | 2019 | |
| Lilly USA, LLC | $28.41 | 2019 | |
| Array Biopharma INC | $25.64 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $24.70 | 2019 | |
| Spectrum Pharmaceuticals INC. | $21.99 | 2019 | |
| Shionogi INC | $21.45 | 2019 | |
| Janssen Pharmaceuticals, INC | $20.90 | 2019 | |
| Shire North American Group INC | $20.05 | 2019 | |
| Aurobindo Pharma USA, INC. | $19.75 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $18.01 | 2019 | |
| Sun Pharmaceutical Industries INC. | $16.42 | 2019 | |
| Abbvie INC. | $15.00 | 2019 | |
| Kite Pharma, INC. | $14.44 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $13.94 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.51 | 2019 | |
| Gilead Sciences, INC. | $12.87 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Donovan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.